Sign up online today & collaborate
or click here to find out more
Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a medical device company specializing in the treatment of wounds and skin defects, today said a branch of the U.S. Military says the U.S. Department of Defense ‘wants to use’ the company’s ReCell® technology, which it described as offering a possible ‘paradigm shift’ in skin injury treatment.
The July/August 2015 issue of Army Technology Magazine, in an article titled “Innovative treatments offer hope for burn victims,” explored new strategies being evaluated by the Armed Forces Institute of Regenerative Medicine. The Fort Detrick, Maryland-based group has a stated goal to resolve if regenerative medicine – with its potential to use a patient’s own repair mechanisms – can be used to heal traumatic wounds faster, and reduce scarring, contractures and disability amongst U.S. military personnel.
“The DOD wants to use these technologies to treat complex traumatic injuries,” explained Kristi Pottol, Program Director of the Tissue Injury and Regenerative Medicine Project Management Office.
The article explained how Avita Medical’s device took only 30 minutes to use a patient’s own cells to create a healing suspension, which can treat a skin wound 80 times larger than the skin sample taken. The device was one of two regenerative medicine technologies covered in the article, which explained that “ReCell speeds the healing process, decreases the need to harvest skin from donor sites and improves the appearance of the burn scars.”
For more click here
Source: Medical net